Addition: Aspo @€5.86 / 15.08.2025.
Aspo sold Leipurin for 63 million euros. That is, the business that affected the result the least. Approximately 34% of Aspo’s market value (185 million euros) / 15% of the company’s value (428 million euros) sounds like a good price. Leipurin’s share of Aspo’s operating profit has been approximately 18% in recent years.
A small addition; weight now 1.1% and my portfolio’s 25th largest position.